Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer

Research output: Contribution to conference book › Conference abstract

Original language	English
Publication status	Published - 2023
Event	67th Annual Meeting of the Society of Thrombosis and Haemostasis Research - Frankfurt, Germany Duration: 21 Feb 2023 → 24 Feb 2023

Conference	67th Annual Meeting of the Society of Thrombosis and Haemostasis Research
Country/Territory	Germany
City	Frankfurt
Period	21/02/23 → 24/02/23

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
Englisch, C. (Author), Moik, F. (Author), Thaler, J. (Author), Koder, S. (Author), Preusser, M. (Author), Pabinger, I. (Author) & Ay, C. (Author)
2023
Activity: Talk, presentation or poster › Scientific talk or presentation › On site

@conference{1a2eb6de69194a63a594af33af8eb2c1,

title = "Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer",

author = "C Englisch and Florian Moik and J Thaler and S Koder and M Preusser and I Pabinger and C Ay",

year = "2023",

language = "English",

note = "67th Annual Meeting of the Society of Thrombosis and Haemostasis Research ; Conference date: 21-02-2023 Through 24-02-2023",

}

TY - CONF

T1 - Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer

AU - Englisch, C

AU - Moik, Florian

AU - Thaler, J

AU - Koder, S

AU - Preusser, M

AU - Pabinger, I

AU - Ay, C

PY - 2023

Y1 - 2023

M3 - Conference abstract

T2 - 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research

Y2 - 21 February 2023 through 24 February 2023

ER -